登录

Lachesis Raises 300 Million Yuan Financing

作者: Mailman 2020-10-22 15:25
联新
http://www.lachesis-mh.com/
企业数据由 动脉橙 提供支持
智慧病房解决方案提供商 | 战略融资 | 运营中
中国-广东
2020-10-22
融资金额:RMB¥3亿
深创投
查看

Lachesiss completed 300 million yuan strategic financing, led by the old shareholder Shenzhen Capital Group Company, and followed by SoftBank China Capital and several local private equities.


Shenzhen Lachesis Mobile Medical Technology Co., Ltd. is a high-tech enterprise that focuses on clinical applications, provides intelligent products and services for the management of doctors, nurses, patients and hospitals, and gradually realizes the construction of smart medical services by starting from smart wards. 


Located in Shekou Net Valley, Shenzhen,  Lachesis is a state-level high-tech enterprise, a dual-soft certification enterprise, Vice Chairman Unit of China Medical Equipment Artificial Intelligence Alliance, and Guangdong AI and IoT Clinical Application Engineering Research Center. Lacgesis has been included into Top 100 Future Healthcare Enterprises in 2018 and 2019 as the only one from the field of smart wards.


The overall solution of the smart ward includes two platforms: the smart ward interaction platform and the Internet of Things platform. In the three scenarios of the hospital nurse station, corridor and ward, four categories of products are applied: clinical care, early risk discovery, drug and item management, and mobile rounds , To realize timely reminding of early warning information, real-time risk monitoring and inquiries at any time, transforming post-event processing into active discovery before the event, effective supervision during the event, and feedback enhancement after the event.


At present, Lachesiss marketing network covers more than 6,000 hospitals across the country and has accumulated more than 900 users, including Peking Union Medical College Hospital, Peking University People’s Hospital, Beijing Hospital of the Ministry of Health and other domestic well-known tertiary hospitals. It has accumulated strong in the field of smart medical care. Demonstration effect.


>>>>

About Shenzhen Capital Group


Shenzhen Capital Group Company, Ltd. (“SCGC”)is a leading venture capital firm (“VC”) in China.Co-founded by the Shenzhen Municipal Government and a group of private partners in August 1999, SCGC is now a privately and independently managed VC. Since its inception, SCGC has continuously fundedprivate industries, supported private brands and stimulated economic growth with VC investments into up-and-coming companies throughout the world.



相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

2020CMEF即将落幕,七大趋势解码医疗器械行业

2020-10-22
下一篇

踩在“高压线”上的医药代表,被转型还是被消亡?

2020-10-23